Retraction notice to "Anticancer and anti-metastasis activity of 1,25 dihydroxycholecalciferols and genistein in MCF-7 and MDA-MB-231 breast cancer cell lines" [Heliyon 9 (2023) e21975]

Authors

Institutions

Publication Details

Journal
Heliyon
Published
2025-10-01
DOI
https://doi.org/10.1016/j.heliyon.2025.e43994
Primary Topic
Cytokine Signaling Pathways and Interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retraction notice to "Anticancer and anti-metastasis activity of 1,25 dihydroxycholecalciferols and genistein in MCF-7 and MDA-MB-231 breast cancer cell lines" [Heliyon 9 (2023) e21975]

Uzma Faridi, Fatema Suliman Alatawi
Heliyon
Cytokine Signaling Pathways and Interactions
article

Retraction notice to "Anticancer and anti-metastasis activity of 1,25 dihydroxycholecalciferols and genistein in MCF-7 and MDA-MB-231 breast cancer cell lines" [Heliyon 9 (2023) e21975]

Uzma Faridi, Fatema Suliman Alatawi
article en

Abstract

No abstract available for this paper.
HeliyonVol. 11(15)
University of Tabuk (SA)
Openalex Percentile: Top 62%
Cytokine Signaling Pathways and Interactions
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Retraction notice to "Anticancer and anti-metastasis activity of 1,25 dihydroxycholecalciferols and genistein in MCF-7 and MDA-MB-231 breast cancer cell lines" [Heliyon 9 (2023) e21975] — Uzma Faridi, Fatema Suliman Alatawi · Heliyon (2025) | TGRS Research Map | TGRS